Healthcare Unfiltered: Multiple Myeloma With Multiple Guests: A Stakeholder Roundtable on Apple Podcasts
Show Healthcare Unfiltered, Ep Multiple Myeloma With Multiple Guests: A Stakeholder Roundtable – May 31, 2022
Show Healthcare Unfiltered, Ep Multiple Myeloma With Multiple Guests: A Stakeholder Roundtable – May 31, 2022
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
My esteemed guest on this Healthcare unfiltered podcast is Dr. Manmeet Ahluwalia, Deputy Director, Chief Scientific Officer, and Chief of Solid Tumor Medical…
Show Healthcare Unfiltered, Ep Advances in Primary Brain Cancers With Manmeet Ahluwalia – Apr 30, 2024
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
Alan Skarbnik, MD, and Manni Mohyuddin, MBBS, discuss the concept of MRD in hematologic malignancies.
In this special episode of Healthcare Unfiltered, I delve into the realm of AI and its transformative impact on drug development with Adam Petrich, MD,…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Show Healthcare Unfiltered, Ep AI and Drug Development With Adam Petrich – Apr 23, 2024
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether…